Nov. 6, 2014, 11:21 AM
- Capstone Therapeutics (OTCQB:CAPS) will report Q3 results on November 13 after the close. The conference call will begin at 4:30 pm ET.
Aug. 14, 2014, 11:10 AM
- Capstone Therapeutics (OTCQB:CAPS) Q2 results: Revenues: $0; Operating Expenses: $1.4M (+35.9%); Net Loss: ($1.4M) (-38.0%); Loss Per Share: ($0.03) (-50.0%); Quick Assets: $4.2M (-33.0%).
- No financial guidance given.
Capstone Therapeutics Corp. is a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions.
Country: United States
Other News & PR